Tetrahydro-1H-pyrrolizin-7a(5H)-ylacetic acid hydrochloride, 97.0%, 250mg

n-(3-Bromobenzyl)cyclopropanamine, 95%, 10g

5-Methyl-4-nitrothiophene-2-carboxylic acid, 95.0%, 10g

2-Methyl-tetrahydro-furan-2-carboxylic acid, 95.0%, 250mg

Ruthenium dioxide hydrate, 95.0%, 1g

ISOORIENTIN, 99%, 250mg

(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(4-chlorophenyl)propanoic acid, 98%, 10g

6,7-DIHYDRO-5H-PYRROLO[3,4-D]PYRIMIDINE, 95.0%, 250mg

6-Bromo-8-fluoro-[1,2,4]triazolo[1,5-a]pyridine, 97.0%, 5g

GC capillary column ROTI®Cap-1701, 50 m, 0.32 mm, 1.00 µm, 1 Piece(s)

Methyl 2-bromo-3-methyl-3H-imidazo[4,5-b]pyridine-6-carboxylate, 95.0%, 250mg

2,4-Dichlorobenzyl alcohol, 97.0%, 500g

2-(4-Chloro-2-fluoro-5-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g